FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine, more specifically clinical pharmacology, and can be used for pharmacological correction of the CNS diseases, and concerns drugs exhibiting psychostimulant action and prepared of inorganic (mineral) raw materials. The agent exhibits psychostimulant action, contains magnesium sulphate, ferric (II) sulphate, copper (II) sulphate and chrome (III) chloride.
EFFECT: psychostimulant agent extends the range of products exhibiting psychostimulant action, with high specific action.
5 ex, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
AGENT SHOWING ANXIOLYTIC ACTION | 2011 |
|
RU2464990C1 |
NOOTROPIC AGENT | 2011 |
|
RU2475250C1 |
NOOTROPIC AGENT | 2012 |
|
RU2493856C1 |
BIOLOGICALLY ACTIVE FOOD ADDITIVE | 2013 |
|
RU2552006C1 |
AGENT POSSESSING NORMOTHYMIC ACTIVITY | 2011 |
|
RU2470646C1 |
MEDICATION, PROVIDING NEURO-PROTECTIVE ACTION IN ACUTE PERIOD OF CRANIOCEREBRAL INJURY | 2009 |
|
RU2414901C2 |
GAMMA-AMINOBUTYRIC ACID DERIVATIVE, HAVING NOOTROPIC ACTIVITY COUPLED WITH TRANQUILISING ACTIVITY | 2012 |
|
RU2495866C1 |
ACTIVE INGREDIENT OF MEDICINAL AGENT WITH CEREBROPROTECTIVE, ANTIHYPOXIC AND ANTIAMNESTIC ACTIVITY FOR TREATMENT AND PREVENTION OF NEURODEGENERATIVE DISEASES AND METHOD FOR PREPARING THE SAME | 2023 |
|
RU2821508C1 |
METHOD FOR PREPARATION OF FODDER ADDITIVE FOR YOUNG CATTLE | 2019 |
|
RU2711259C1 |
ANTI-ARRHYTHMIC PREPARATION | 2002 |
|
RU2223759C1 |
Authors
Dates
2012-01-10—Published
2010-06-30—Filed